As of Thursday close, Cano Health Inc.’s (NYSE:CANO) stock was down -$0.01, moving down -3.49 percent to $0.31. The average number of shares traded per day over the past five days has been 34,893,098 shares. 1 time new highs have been achieved over the past 5 days, with a $0.0793 gain in that time frame. In the last twenty days, the average volume was 23,945,125, while in the previous 50 days, it was 11,681,018.
Since last month, CANO stock retreated -78.52%. Shares of the company fell to $0.2210 on 08/24/23, the lowest level in the past month. A 52-week high of $9.75 was reached on 02/08/23 after having rallying from a 52-week low of $0.22. Since the beginning of this year, CANO’s stock price has dropped by -77.42% or -$1.0607, and marked a new high 7 times. However, the stock has declined by -96.83% since its 52-week high.
CANO stock investors should be aware that Cano Health Inc. (CANO) stock had its last reported insider trading activity 21 days ago on Aug 11. Camerlinck Robert, the Chief Operating Officer of the company, disposed of 30,646 shares for $0.77 on Aug 11. It resulted in a $23,453 divestment by the insider. Aguilar Richard sold 400,000 shares at an average price of $1.31 on Jun 29. The insider now owns 1,213,984 shares following the transaction. On Jun 28, Chief Clinical Officer Aguilar Richard sold 150,000 shares at $1.22 apiece. The transaction was valued at $183,300.
Valuation Metrics
The stock’s beta is 0.22. Besides these, the trailing price-to-sales (P/S) ratio of 0.04, the price-to-book (PB) ratio of 0.58.
Financial Health
According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 6.34, and the total debt-to-equity ratio was 7.11. In the year ended June 29, EBITDA margin amounted to 0.60%, whereas operating margins totaled -22.80%. Based on annual data, CANO earned $3.18 billion in gross profit and brought in $2.74 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -34.90%. Return on equity (ROE) for the past 12 months was -136.70%.
In Cano Health Inc.’s quarter-end financial report for June 29, it reported total debt of $922.23 million. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. CANO’s revenue rose 10.09% to $866.91 million during the quarter, while net income inched up to $766.75 million. While analysts expected Cano Health Inc. to report -$0.12 quarterly earnings, the actual figure was -$0.51 per share, beating the consensus estimate by -325.00%. During the quarter, the company generated -$216.94 million in EBITDA. The liabilities of Cano Health Inc. were 1.47 billion at the end of its most recent quarter ended June 29, and its total debt was $1.23 billion. The value of shareholders’ equity is $538.68 million.
Technical Picture
This quick technical analysis looks at Cano Health Inc.’s (CANO) price momentum. With a historical volatility rate of 242.78%, the RSI 9-day stood at 27.00% on 31 August.
With respect to its five-day moving average, the current Cano Health Inc. price is up by +34.48% percent or $0.0793. At present, CANO shares trade -79.92% below its 20-day simple moving average and -77.91% percent below its 100-day simple moving average. However, the stock is currently trading approximately -78.06% below its SMA50 and -86.78% below its SMA200.
Stochastic coefficient K was 17.05% and Stochastic coefficient D was 10.93%, while ATR was 0.1050. Given the Stochastic reading of 27.01% for the 14-day period, the RSI (14) reading has been calculated as 27.85%. As of today, the MACD Oscillator reading stands at 0.0202, while the 14-day reading stands at -0.0252.
Analyst Ratings
Cano Health Inc. downgraded its rating on Cano Health Inc. (NYSE: CANO) to a Hold in a note to investors on August 11, 2023. The analysts firm previously had a Buy rating on the stock.Cano Health Inc. (CANO) has been rated Hold by analysts. According to 1 brokerage firm, CANO is a sell, and 6 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 0 analysts rate Cano Health Inc. stock as buy, with 1 recommending it as overweight.
With a median target price of $0.80, the current consensus forecast for the stock is $0.50 – $2.00. Based on these forecasts, analysts predict Cano Health Inc. (CANO) will achieve an average price target of $0.97.
